Finnish Deputy Ombudsman warns healthcare fee hikes threaten fundamental rights and may worsen health inequalities
By
Sakri Pölönen HS
Summary
The Deputy Parliamentary Ombudsman of Finland, Susanna Lindroos-Hovinheimo, has issued a statement criticizing proposed increases to healthcare customer fees. She considers the new fees and fee hikes to be "remarkably large" from the customers' perspective and warns they may push essential services out of reach for those who need them, potentially widening health inequalities. The government decided in its spring budget framework to seek approximately 90 million euros in savings through these fee increases.
Source
bskyFinnish Deputy Ombudsman warns healthcare fee hikes threaten fundamental rights and may worsen health inequalitieshs.fiKey quotes
· 2 pulledPidän uusia maksuja ja maksujen korotuksia kokonaisuutena arvioiden asiakkaiden kannalta huomattavan suurina
Ehdotetut asiakasmaksut suuruudellaan ovat siirtämässä palveluja niitä tarvitsevien ulottumattomiin
You might also wanna read
UK-US pharmaceuticals deal will divert £45bn from essential NHS services, says doctors' union
Conflicts of interest threaten integrity of GLP-1 therapy guidance, experts warn
This article discusses the risks of conflicts of interest in clinical guidance for GLP-1 receptor agonists (like Ozempic, Wegovy) used for o
bit.ly·18d ago
NHS trusts fail to account for over £400m in medical student training funds, BMJ investigation finds
An investigation by The BMJ reveals that NHS trusts in England have failed to account for over £400 million (nearly a quarter) of the £1.7 b
bmj.com·15d ago
The Case Against Constant Mental Health Discourse: A Critical Look at Awareness Culture
The article critiques the mainstream mental health discourse, arguing that the constant public conversation about mental health has become c
compactmag.com·12d ago
Critics question consent, clinical utility, and industry influence in UK's Our Future Health programme
The BMJ investigates concerns about the UK's Our Future Health (OFH) programme, the country's largest ever health research initiative with 1
bmj.com·13d ago
Analysis: UK-US pharmaceuticals trade deal could divert NHS funds and harm public health
This article argues that the UK-US pharmaceuticals trade deal, announced on 1 December 2025, will harm public health by diverting billions o
bmj.com·5d agoAnalysis: UK-US pharmaceuticals trade deal could divert NHS funds and harm public health
This article argues that the UK-US pharmaceuticals trade deal, announced on 1 December 2025, will harm public health by diverting billions o
bmj.com·5d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.